Iodide

Iodide

SCHEMBL7033663

CC1=[N+](C)c2ccc(C(=O)O)cc2C1(C)C.[I-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
MAPT P10636 4/20 0.43
THRB P10828 4/20 0.43
KMT2A Q03164 4/20 0.43
NPC1 O15118 3/20 0.43
POLB P06746 3/20 0.43
RAB9A P51151 3/20 0.43
LMNA P02545 3/20 0.43
RECQL P46063 3/20 0.43
ALDH1A1 P00352 3/20 0.43
S1PR4 O95977 2/20 0.43
ALPG P10696 2/20 0.43
PKM P14618 2/20 0.43
S1PR1 P21453 2/20 0.43
NTSR1 P30989 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7849455 0.98 VDR (0.41) MEN1MAPTTHRBKMT2ANPC1
SCHEMBL26782782 0.84 TDP1 (0.43) MEN1MAPTTHRBKMT2ANPC1
SCHEMBL26782797 0.81 SMN1; SMN2 (0.47) MEN1MAPTTHRBKMT2ANPC1
Iodide SCHEMBL20975473 0.80 MEN1 (0.35) MEN1MAPTTHRBKMT2ALMNA
SCHEMBL26782791 0.80 LTA4H (0.38) MEN1MAPTTHRBKMT2ANPC1
SCHEMBL27278164 0.79 RARA (0.38) MEN1KMT2APOLBALDH1A1SMN1; SMN2
Iodide SCHEMBL20975474 0.79 THRB (0.47) MEN1MAPTTHRBKMT2ANPC1
Iodide SCHEMBL4701241 0.77 MEN1 (0.42) MEN1MAPTTHRBKMT2ANPC1
SCHEMBL29271029 0.77 THRB (0.44) MEN1MAPTTHRBKMT2ANPC1
Iodide SCHEMBL2587637 0.76 MEN1 (0.48) MEN1MAPTTHRBKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377562-B2 Squaraine dyes and applications thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-07-05 US claimed
US-20190270889-A1 SQUARAINE DYES AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-09-05 US claimed
WO-2018020518-A1 SQUARAINE DYES AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-02-01 WO claimed
CN-105733564-A Mitochondrially-targeted pH-sensitive ratio-type fluorescent probe and preparation method and application thereof 郑州大学 2016-07-06 CN claimed
US-11377562-B2 Squaraine dyes and applications thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-07-05 US disclosed
EP-3307817-B1 NOVEL SPIROPYRAN BASED COMPOSITION AND APPLICATION THEREOF AS SECURITY TAG COUNCIL SCIENT IND RES (IN) 2020-11-04 EP disclosed
US-10723883-B2 Spiropyran based composition and application thereof as security tag COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2020-07-28 US disclosed
US-20190270889-A1 SQUARAINE DYES AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-09-05 US disclosed
US-20180163053-A1 Novel Spiropyran Based Composition and Application Thereof as Security Tag COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-06-14 US disclosed
EP-3307817-A1 NOVEL SPIROPYRAN BASED COMPOSITION AND APPLICATION THEREOF AS SECURITY TAG Council of Scientific and Industrial Research (IN) 2018-04-18 EP disclosed
WO-2018020518-A1 SQUARAINE DYES AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-02-01 WO disclosed
WO-2016199173-A1 NOVEL SPIROPYRAN BASED COMPOSITION AND APPLICATION THEREOF AS SECURITY TAG COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-12-15 WO disclosed
CN-105733564-A Mitochondrially-targeted pH-sensitive ratio-type fluorescent probe and preparation method and application thereof 郑州大学 2016-07-06 CN disclosed
US-20030095924-A1 Galenical formulations SCHERING AKTIENGESELLSCHAFT (DE) 2003-05-22 US disclosed
US-6447749-B1 Perfluoro-alkyl containing dye molecules and galencial formulations SCHERING AKTIENGESELLSCHAFT (DE) 2002-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030095924-A1 Galenical formulations GALR1, GALR2, LGALS1 MEN1 1210/4885MAPT 1990/4885THRB 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.